» Articles » PMID: 6476152

Blood-brain Barrier Transport and Brain Sequestration of Propranolol and Lidocaine

Overview
Journal Am J Physiol
Specialty Physiology
Date 1984 Sep 1
PMID 6476152
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Lipophilic amine drugs such as propranolol and lidocaine are actively sequestered by tissues via saturable cytoplasmic binding systems. The present studies were designed to characterize the kinetics of drug transport and sequestration in rat brain in vivo by using the carotid injection technique. Both propranolol and lidocaine are sequestered by brain, and the half time (t 1/2) of clearance of the drugs from brain to blood is 6-7 min. The t 1/2 of propranolol association and dissociation reactions with the brain sequestration system are 0.38 +/- 0.03 and 1.33 +/- 0.20 min, respectively. The blood-brain barrier transport of propranolol and lidocaine is inhibited by acid pH, and drug transport is mediated by a low-affinity, high-capacity saturable transport system [propranolol half-saturation constant (Km) = 9.8 +/- 1.2 mM, maximal rate of saturable transport (Vmax) = 5.7 +/- 0.7 mumol X min-1 X g-1, and nonsaturable transport constant (KD) = 0.061 +/- 0.012 ml X min-1 X g-1). These studies indicate that in addition to cerebral blood flow, the distribution of lipophilic amines in brain is a function of plasma pH and of the activity of brain sequestration systems. The latter may represent high-capacity cytoplasmic drug-binding proteins that normally bind endogenous ligands in brain.

Citing Articles

Physiologically Based Pharmacokinetic Model of Brain Delivery of Plasma Protein Bound Drugs.

Pardridge W Pharm Res. 2023; 40(3):661-674.

PMID: 36829100 PMC: 10036418. DOI: 10.1007/s11095-023-03484-2.


A Historical Review of Brain Drug Delivery.

Pardridge W Pharmaceutics. 2022; 14(6).

PMID: 35745855 PMC: 9229021. DOI: 10.3390/pharmaceutics14061283.


Propranolol produces short-term facilitation of extinction in a rabbit model of post-traumatic stress disorder.

Burhans L, Smith-Bell C, Schreurs B Neuropharmacology. 2018; 135:386-398.

PMID: 29578033 PMC: 5975200. DOI: 10.1016/j.neuropharm.2018.03.029.


Characterization of an in vitro blood-brain barrier model system for studying drug transport and metabolism.

Audus K, Borchardt R Pharm Res. 2013; 3(2):81-7.

PMID: 24271465 DOI: 10.1023/A:1016337202335.


Propranolol inhibition of β-adrenergic receptor does not suppress pathologic neovascularization in oxygen-induced retinopathy.

Chen J, Joyal J, Hatton C, Juan A, Pei D, Hurst C Invest Ophthalmol Vis Sci. 2012; 53(6):2968-77.

PMID: 22491401 PMC: 3376075. DOI: 10.1167/iovs.12-9691.